C07C 311/22
Sulfonamides, the carbon skeleton of the acid part being further substituted by
Official title: Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
C07C311/22 (Sulfonamides, the carbon skeleton of the acid part being further substituted by) appears on 824 US grants and 773 published applications in this corpus.
Search patents in C07C- Granted patents
- 824
- Published applications
- 773
- Assignees
- 456
- Inventors
- 2,934
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 7 | 0 |
| 1991 | 6 | 0 |
| 1992 | 5 | 0 |
| 1993 | 14 | 0 |
| 1994 | 13 | 0 |
| 1995 | 19 | 0 |
| 1996 | 12 | 0 |
| 1997 | 17 | 0 |
| 1998 | 35 | 0 |
| 1999 | 36 | 0 |
| 2000 | 34 | 0 |
| 2001 | 50 | 9 |
| 2002 | 33 | 40 |
| 2003 | 39 | 48 |
| 2004 | 21 | 58 |
| 2005 | 26 | 48 |
| 2006 | 26 | 48 |
| 2007 | 39 | 42 |
| 2008 | 28 | 46 |
| 2009 | 27 | 48 |
| 2010 | 29 | 39 |
| 2011 | 33 | 43 |
| 2012 | 37 | 29 |
| 2013 | 26 | 23 |
| 2014 | 26 | 37 |
| 2015 | 31 | 33 |
| 2016 | 20 | 20 |
| 2017 | 18 | 26 |
| 2018 | 22 | 16 |
| 2019 | 17 | 17 |
| 2020 | 10 | 20 |
| 2021 | 12 | 7 |
| 2022 | 9 | 22 |
| 2023 | 8 | 13 |
| 2024 | 14 | 18 |
| 2025 | 8 | 10 |
| 2026 | 7 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Prodrugs of STAT3 inhibitors5 May 2026US 12,617,810 B2Tvardi Operating Company, Inc.
- Calpain-2 inhibitor compounds and methods of treatment21 Apr 2026US 12,606,520 B2Western University of Health Sciences
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Kif18a inhibitor compound, and pharmaceutical composition and preparation method therefor and use thereof1 Oct 2026US 2026/0294927 A1Changchun Genescience Pharmaceutical Co., Ltd.
- Novel mitofusin inhibitors17 Sep 2026US 2026/0274810 A1Albert Einstein College of Medicine
- Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators10 Sep 2026US 2026/0265190 A1Rappta Therapeutics Oy
- Agonists of small heterodimer partner for cancer therapy3 Sep 2026US 2026/0257992 A1The Board of Trustees of the University of Illinois
- Methods and compositions for prevention of anaphylaxis20 Aug 2026US 2026/0242369 A1Baylor College of Medicine
Most cited
By later US patents
- Phenyl heterocycles as cox-2 inhibitors281US 5,474,995 AMerck Frosst Canada, Inc. · 1995
- Arylsulfonylamino hydroxamic acid derivatives213US 5,863,949 APfizer Inc. · 1999
- Phenyl heterocycles as cox-2 inhibitors208US 5,550,142 AMerck Frosst Canada, Inc. · 1996
- Phenyl heterocycles as COX-2 inhibitors204US 5,536,752 AMerck Frosst Canada, Inc. · 1996
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996